Medicare Enrolled
Dr. James Azurin, MD MS
Neurology · Rochester, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Azurin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Azurin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Azurin
Dr. James Azurin is a neurology specialist in Rochester, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Azurin performed 9,312 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Azurin received a total of $17,945 from 79 pharmaceutical and/or device companies across 1096 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Azurin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 9% volume in NY
$17,945 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗9,312
Medicare services
Top 9% in NY for neurology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
8,800 | $5 | $7 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
140 | $88 | $167 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
101 | $74 | $125 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
80 | $116 | $249 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
62 | $65 | $138 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
33 | $103 | $285 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
28 | $130 | $296 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
24 | $132 | $220 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
16 | $162 | $350 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
15 | $95 | $250 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
13 | $290 | $550 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$17,945
Total received (2018-2024)
Avg $2,564/year across 7 years
Top 19% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
79
Companies
1,096
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,127
2023
$2,383
2022
$730
2021
$1,771
2020
$2,085
2019
$4,084
2018
$3,766
Payments by company (2024)
ABBVIE INC.
$681
PFIZER INC.
$294
EMD Serono, Inc.
$269
Teva Pharmaceuticals USA, Inc.
$207
UCB, Inc.
$171
Genentech USA, Inc.
$153
Lilly USA, LLC
$124
MDD US Operations, LLC
$121
Lundbeck LLC
$87
ARGENX US, INC.
$78
Neurocrine Biosciences, Inc.
$78
CSL Behring
$74
Alexion Pharmaceuticals, Inc.
$71
Amgen Inc.
$68
Amneal Pharmaceuticals LLC
$64
SK Life Science, Inc.
$63
TG Therapeutics, Inc.
$55
Eisai Inc.
$51
Biogen, Inc.
$46
Octapharma USA, Inc.
$45
Takeda Pharmaceuticals U.S.A., Inc.
$38
Grifols USA, LLC
$31
Merz Pharmaceuticals, LLC
$30
JAZZ PHARMACEUTICALS INC.
$29
Alnylam Pharmaceuticals Inc.
$27
Nevro Corp.
$26
Axsome Therapeutics, Inc.
$25
Otsuka America Pharmaceutical, Inc.
$25
Celgene Corporation
$24
SCILEX PHARMACEUTICALS INC.
$21
Neurelis, Inc.
$19
HARMONY BIOSCIENCES LLC
$17
Kyowa Kirin, Inc.
$14
Top 3 companies account for 39.8% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$1,260
EMD Serono, Inc.
$1,206
Genentech USA, Inc.
$1,158
Biogen, Inc.
$1,039
Lundbeck LLC
$880
ABBVIE INC.
$873
Amgen Inc.
$787
GENZYME CORPORATION
$707
Novartis Pharmaceuticals Corporation
$659
PFIZER INC.
$585
Lilly USA, LLC
$540
Sunovion Pharmaceuticals Inc.
$520
AbbVie Inc.
$478
Neurocrine Biosciences, Inc.
$402
UCB, Inc.
$351
Allergan Inc.
$321
Acorda Therapeutics, Inc
$303
US WorldMeds, LLC
$292
ARGENX US, INC.
$280
Alexion Pharmaceuticals, Inc.
$262
Jazz Pharmaceuticals Inc.
$255
Avanir Pharmaceuticals, Inc.
$231
Promius Pharma LLC
$211
SK Life Science, Inc.
$194
Celgene Corporation
$194
ARBOR PHARMACEUTICALS, INC.
$191
Adamas Pharmaceuticals, Inc.
$176
MDD US Operations, LLC
$176
JAZZ PHARMACEUTICALS INC.
$173
CSL Behring
$173
Grifols USA, LLC
$168
AbbVie, Inc.
$152
Takeda Pharmaceuticals U.S.A., Inc.
$145
Supernus Pharmaceuticals, Inc.
$139
Biohaven Pharmaceuticals, Inc.
$128
Kyowa Kirin, Inc.
$128
Zyla Life Sciences
$111
Mallinckrodt Enterprises LLC
$99
Mallinckrodt LLC
$97
Alnylam Pharmaceuticals Inc.
$89
Upsher-Smith Laboratories LLC
$88
Merz Pharmaceuticals, LLC
$86
ASSERTIO THERAPEUTICS, Inc.
$79
Janssen Pharmaceuticals, Inc
$78
Amneal Pharmaceuticals LLC
$77
Allergan, Inc.
$74
Mallinckrodt Hospital Products Inc.
$72
TG THERAPEUTICS, INC.
$67
Eisai Inc.
$63
GE HEALTHCARE
$61
Akcea Therapeutics, Inc.
$61
Neurelis, Inc.
$59
Ipsen Biopharmaceuticals, Inc
$57
LivaNova USA, Inc.
$57
Horizon Therapeutics plc
$55
TG Therapeutics, Inc.
$55
Bayer HealthCare Pharmaceuticals Inc.
$50
UPSHER-SMITH LABORATORIES LLC
$48
Axsome Therapeutics, Inc.
$47
Otsuka America Pharmaceutical, Inc.
$46
Octapharma USA, Inc.
$45
Almatica Pharma LLC
$40
IMPEL PHARMACEUTICALS INC.
$40
Merz North America, Inc.
$39
MITSUBISHI TANABE PHARMA AMERICA, INC.
$38
E.R. Squibb & Sons, L.L.C.
$36
Mitsubishi Tanabe Pharma America, Inc.
$36
Catalyst Pharmaceuticals, Inc.
$31
Nevro Corp.
$26
Biohaven Pharmaceutical Holding Company Ltd.
$25
Zyla Life Sciences, Inc.
$25
Impax Laboratories, Inc.
$23
IDORSIA PHARMACEUTICALS US INC
$22
BANNER LIFE SCIENCES, LLC
$22
SCILEX PHARMACEUTICALS INC.
$21
Mylan Pharmaceuticals Inc.
$18
HARMONY BIOSCIENCES LLC
$17
Abbott Laboratories
$14
Merck Sharp & Dohme Corporation
$14
Top 3 companies account for 20.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adempas · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COMIRNATY · COPAXONE · Cambia · DUOPA · DYSPORT · Dayvigo · Duopa · Dysport · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · FABRY-DISEASE · FIRDAPSE · Fintepla · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Glatiramer Acetate · Gocovri · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · JARDIANCE · KISUNLA · KYNMOBI · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONPATTRO · Ocrevus · PANZYGA · PAXLOVID · PLEGRIDY · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPRIX · SUNOSI · Senza · Soliris · Sunosi · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · XEOMIN · XYREM · Xadago · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zinbryta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
107
County median income
$74,409
Nearest hospital to ZIP centroid (approximate)
ROCHESTER PSYCHIATRIC CENTER
2.7 mi
2.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Azurin is a mixed practice specialist, with above-average Medicare volume (top 9% in NY), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Azurin experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Azurin performed 8,800 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Azurin receive payments from pharmaceutical companies?
Yes. Dr. Azurin received a total of $17,945 from 79 companies across 1,096 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Azurin's costs compare to other neurologists in Rochester?
Dr. Azurin's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Azurin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Rochester
Browse neurologists in Rochester ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology